ÿþ<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"> <html> <head> <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"> <title>Alzheimer's Conference / Parkinson's Conference: ADPD 2009 - Prague, March 11-15 - Poster Presentations</title> <style> body { background-color:#fbecb3; background-image:url(http://www.kenes.com/adpd/images/bg.jpg); background-repeat:repeat-x; margin:0px; } h1 { font-family:Verdana, Arial; font-size: 16px; font-weight:bold; color: #cb181c; } h2 { font-family:Verdana, Arial; font-size: 14px; font-weight:bold; color: #c52e23; } table { border-right:1px solid #e19c4f; border-left:1px solid #e19c4f; background-color:white; } td { font-family:Verdana, Arial; font-size: 12px; font-weight:normal; color: #333333; } .content { padding:10px; } </style> </head> <body> <table width="750" align="center" border="0" cellspacing="0" cellpadding="0"> <tr> <td><img src="http://www.kenes.com/adpd/images/ei_top.jpg" /></td> </tr> <tr> <td class="content"><h1>Poster Presentations</h1> <P><b><u>Friday, March 14  Saturday, March 15, 2009</u></b></P><H2>Novel Pharmacological Compounds:<br /></H2><p> <a href='Abstract1137.htm'><b>PDE7 INHIBITORS AS NOVEL POTENTIAL DRUGS FOR NEURODEGENERATIVE DISORDERS</b></a><br> C. Gil<sup>1</sup>, M. Redondo<sup>1</sup>, C. Perez<sup>1</sup>, J.A. Morales-Garcia<sup>2</sup>, T. Castaño<sup>1</sup>, N. Campillo<sup>1</sup>, A. Perez-Castillo<sup>2</sup>, <b>A. Martinez</b><sup>1</sup><br> <em><sup>1</sup>CSIC, Instituto de Quimica Medica, Madrid, Spain, <sup>2</sup>CSIC, Instituto de Investigaciones Biomedicas, Madrid, Spain</em><br> </p> <p> <a href='Abstract1138.htm'><b>EFFECT OF ANM176<sup>TM</sup> CONTAINING FERULIC ACID AND GARDEN ANGELICA EXTRACT ON ALZHEIMER´S DISEASE</b></a><br> <b>S. Nakamura</b><sup>1</sup>, K. Sasaki<sup>2</sup><br> <em><sup>1</sup>Rakuwakai Otowa Hospital, Neurology, Kyoto, Japan, <sup>2</sup>Kinoko Espoir Hospital, Psychiary, Kasoka, Japan</em><br> </p> <p> <a href='Abstract1139.htm'><b>CEREBROLYSIN, DONEPEZIL AND A COMBINATION THERAPY IN ALZHEIMER'S DISEASE: RESULTS OF A DOUBLE-BLIND CLINICAL TRIAL </b></a><br> <b>A. Alvarez</b><sup>1</sup>, C. Sampedro<sup>1</sup>, V. Couceiro<sup>1</sup>, R. Cacabelos<sup>1</sup>, M. Aleixandre<sup>2</sup>, M. Vargas<sup>2</sup>, C. Linares<sup>3</sup>, E. Granizo<sup>3</sup>, E. Doppler<sup>4</sup>, P. Novak<sup>4</sup>, H. Moessler<sup>4</sup><br> <em><sup>1</sup>EuroEspes Biomedical Research Centre, A Coruña, Spain, <sup>2</sup>Geroclinic, Granada, Spain, <sup>3</sup>Memory Clinic, Malaga, Spain, <sup>4</sup>Ebewe Pharma, Unterach, Austria</em><br> </p> <p> <a href='Abstract1140.htm'><b>HARNESSING NITRIC OXIDE MIMETIC ACTIVITY IN DRUG CHIMERAS FOR ALZHEIMER'S</b></a><br> <b>G. Thatcher</b>, J. Luo<br> <em>University of Illinois at Chicago, Medicinal Chemistry, Chicago, United States</em><br> </p> <p> <a href='Abstract1141.htm'><b>MEMBRANE-STABILIZING EFFECT OF NOVEL NEUROPROTECTIVE PHARMACOLOGICAL COMPOUND CAPAH: IMPLICATION TO TREATMENT OF ALZHEIMER'S DISEASE</b></a><br> <b>M. Mukhamedyarov</b><sup>1</sup>, I. Semina<sup>1</sup>, E. Yusupova<sup>1</sup>, A. Baychourina<sup>1</sup>, A. Palotas<sup>2</sup>, A. Zefirov<sup>1</sup><br> <em><sup>1</sup>Kazan State Medical University, Kazan, Russian Federation, <sup>2</sup>Asklepios-Med Bt, Szeged, Hungary</em><br> </p> <p> <a href='Abstract1142.htm'><b><i>NUR77</i> IS INVOLVED IN DOPAMINE CELL DEATH AND NEUROPROTECTION</b></a><br> <b>C. Rouillard</b><sup>1</sup>, C. Tremblay<sup>2</sup>, M. St-Hilaire<sup>1</sup>, J. Baillargeon<sup>1</sup>, D. Lévesque<sup>3</sup>, M.-G. Martinoli<sup>2</sup><br> <em><sup>1</sup>Université Laval, Unité de Neuroscience, Québec, Canada, <sup>2</sup>Université du Québec à Trois-Rivières, Département de Chimie-Biologie, Trois-Rivières, Canada, <sup>3</sup>Université de Montréal, Faculté de Pharmacie, Montréal, Canada</em><br> </p> <p> <a href='Abstract1143.htm'><b>PROTECTIVE EFFECT OF Z-LIGUSTILIDE AGAINST AMYLOID </b><b>B</b><b>-INDUCED NEUROTOXICITY IS ASSOCIATED WITH ANTI-NEUROINFLAMMATION IN RATS</b></a><br> <b>J.-R. Du</b>, X. Kuang, Y.-S. Chen, J. Wang<br> <em>West China School of Pharmacy, Sichuan University, Chengdu, China</em><br> </p> <p> <a href='Abstract1144.htm'><b>HIGH MAGNESIUM REVERSES COGNITIVE DEFICITS AND SYNAPTIC LOSS IN ALZHEIMER'S MOUSE MODEL</b></a><br> W. Li<sup>1</sup>, J. Yu<sup>2</sup>, X. Huang<sup>1</sup>, N. Abumaria<sup>1</sup>, Y. Zhu<sup>1</sup>, D. Chui<sup>2</sup>, <b>G. Liu</b><sup>1</sup><br> <em><sup>1</sup>Tsinghua University, Center for Learning and Memory, Beijing, China, <sup>2</sup>Peking University, Neuroscience Research Institute, Health Science Center, Beijing, China</em><br> </p> <p> <a href='Abstract1145.htm'><b>THERAPEUTIC POTENTIAL OF TNF-± SYNTHESIS INHIBITORS IN RODENT MODELS OF NEUROINFLAMMATION</b></a><br> <b>S. Rosi</b><sup>1</sup>, D. Tweedie<sup>2</sup>, R. Ferguson<sup>1</sup>, W. Levy<sup>1</sup>, F. Kelly<sup>1</sup>, W. Luo<sup>2</sup>, H. Holloway<sup>2</sup>, N. Greig<sup>2</sup><br> <em><sup>1</sup>University of California San Francisco, Brain and Spinal Injury Center, Department of Physical Therapy and Rehabilitation Science, San Francisco, United States, <sup>2</sup>National Institute on Aging, NIH, Drug Design & Development Section, Laboratory of Neurosciences, Gerontology Research Center, Baltimore, United States</em><br> </p> <p> <a href='Abstract1146.htm'><b>MULTIFUNCTIONAL TELLURIUM MOLECULE PROTECTS AND RESTORES DOPAMINERGIC NEURONS IN PARKINSON´S DISEASE MODELS</b></a><br> <b>B. Sredni</b><sup>1</sup>, Y. Kalechman<sup>1</sup>, D. Sredni-Kenigsbuch<sup>2</sup>, R. Geffen-Aricha<sup>1</sup>, G. Yadid<sup>3</sup><br> <em><sup>1</sup>Bar Ilan University, C.A.I.R. Institute, Faculty of Life Sciences, Ramat Gan, Israel, <sup>2</sup>Bar Ilan University, Interdisciplinary Department, Ramat Gan, Israel, <sup>3</sup>Bar Ilan University, Faculty of Life Sciences, Ramat Gan, Israel</em><br> </p> <p> <a href='Abstract1147.htm'><b>THERAPEUTIC EFFECT AND PROBABLE MECHANISIM OF RAPAMYCIN ON MPTP - INDUCED PARKINSONISM IN MICE </b></a><br> <b>L. Kangyong</b><sup>1</sup>, L. Chunfeng<sup>2</sup>, R. Chuancheng<sup>1</sup>, L. Liqin<sup>3</sup><br> <em><sup>1</sup>5th Hospital, Fudan University, Shanghai, China, <sup>2</sup>Second Hospital, Soochow University, Suzhou, China, <sup>3</sup>Huashan Hospital, Fudan University, Shanghai, China</em><br> </p> <p> <a href='Abstract1148.htm'><b>EVALUATION OF DIMEBON IN CELLULAR MODEL OF HUNTINGTON'S DISEASE</b></a><br> J. Wu, Q. Li, <b>I. Bezprozvanny</b><br> <em>UT Southwestern Medical Center at Dallas, Physiology, Dallas, United States</em><br> </p> <p> <a href='Abstract1149.htm'><b>TREATMENT WITH ADENOSINE A<sub>2A</sub> RECEPTOR ANTAGONIST COUNTERACT SYMPTOMS AND PREVENT THE DEVELOPMENT OF DYSKINESIA IN THE MITOPARK MOUSE MODEL </b></a><br> <b>D. Marcellino</b><sup>1</sup>, E. Lindqvist<sup>1</sup>, K. Fuxe<sup>1</sup>, C. Müller<sup>2</sup>, L. Olson<sup>1</sup>, D. Galter<sup>1</sup><br> <em><sup>1</sup>Karolinska Institutet, Department of Neuroscience, Stockholm, Sweden, <sup>2</sup>University of Bonn, Pharmaceutical Institute, Bonn, Germany</em><br> </p> <p> <a href='Abstract1150.htm'><b>DISSECTING NEURONAL MACROAUTOPHAGY PATHWAYS IN RESPONSE TO ALPHA-SYNUCLEIN OLIGOMERS</b></a><br> <b>M.L. Mercado</b>, Z. Xu, J. Golembieski, R. Staal, D. Liu, W. Hirst, P. Reinhart, M. Pangalos, A. Wood, R. Martone<br> <em>Wyeth Discovery Research, Neuroscience, Princeton, United States</em><br> </p> <p> <a href='Abstract1151.htm'><b>PHYTOPHARMACOLOGICAL APPROACH FOR MANAGEMENT OF ALZHEIMER'S AND PARKINSON'S DISEASE USING PHARMACOPHORES FROM SIDDHA MEDICINAL PLANTS - A NOVEL INDIAN APPROACH</b></a><br> <b>H. Joshi</b><br> <em>SET College of Pharmacy, Division of Neuropharmacology - Natural Products, Dharwad, India</em><br> </p> <a href='index.asp'>Back</a><br> <p>&nbsp;</p> <p>&nbsp;</p></td> </tr> </table> </body> </html>